Contamination Doctors Generic Drugs In-Vitro 
The Pharma Data
MAY 4, 2021
Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5 Billion and Adjusted Diluted EPS (2) to a Range of $3.55 Now Anticipates Revenues of Approximately $26 Billion for BNT162b2, Reflecting 1.6 Billion Doses Expected to be Delivered in 2021 Under Signed Contracts as of Mid-April 2021. per share amounts). Reported Diluted EPS (1).
XTalks
SEPTEMBER 14, 2020
In the meantime, WHO Director-General, Tedros Ghebreyesus feels that “vaccine nationalism” may prove to be the undoing of the potential to halt the spread of COVID-19. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19.
Expert insights. Personalized for you.
40 
Let's personalize your content